共 21 条
Deubiquitinase USP25 Alleviates Obesity- Induced Cardiac Remodeling and Dysfunction by Downregulating TAK1 and Reducing TAK1-Mediated Inflammation
被引:3
|作者:
Ye, Bozhi
[1
,2
,3
]
Chen, Yanghao
[1
,2
,3
]
Chen, Xudong
[1
,2
,4
]
Xu, Diyun
[1
,2
,3
]
Jiang, Yucheng
[3
]
Lin, Wante
[1
,2
]
Fang, Danhong
[1
,2
,5
]
Xu, Jiachen
[1
,2
]
Han, Jibo
[3
]
Han, Xue
[3
,6
]
Long, Xiaohong
[3
]
Wang, Wei
[7
,8
]
Zhou, Hao
[1
,2
]
Wu, Gaojun
[1
,2
]
Liang, Guang
[1
,2
,3
,6
]
机构:
[1] Wenzhou Med Univ, Affiliated Hosp 1, Dept Cardiol, Wenzhou 325035, Zhejiang, Peoples R China
[2] Wenzhou Med Univ, Affiliated Hosp 1, Key Lab Cardiovasc Dis Wenzhou, Wenzhou 325035, Zhejiang, Peoples R China
[3] Wenzhou Med Univ, Chem Biol Res Ctr, Sch Pharmaceut Sci, Wenzhou, Zhejiang, Peoples R China
[4] Ningbo Hangzhou Bay Hosp, Dept Cardiol, Ningbo, Zhejiang, Peoples R China
[5] Zhejiang Univ, Sir Run Run Shaw Hosp, Sch Med, Dept Cardiol, Hangzhou, Zhejiang, Peoples R China
[6] Hangzhou Med Coll, Sch Pharmaceut Sci, Hangzhou, Zhejiang, Peoples R China
[7] Hangzhou Med Coll, Affiliated Yongkang Peoples Hosp 1, Hangzhou, Zhejiang, Peoples R China
[8] Hangzhou Med Coll, Sch Pharm, Hangzhou, Zhejiang, Peoples R China
来源:
基金:
中国国家自然科学基金;
关键词:
deubiquitinating enzyme;
inflammation;
obesity cardiomyopathy;
TAK1;
USP25;
CARDIOMYOPATHY;
PATHOGENESIS;
HYPERTROPHY;
CONTRIBUTES;
INHIBITION;
INJURY;
D O I:
10.1016/j.jacbts.2024.06.001
中图分类号:
R5 [内科学];
学科分类号:
1002 ;
100201 ;
摘要:
Deubiquitinating enzymes play a vital role in cardiovascular diseases. This study found that cardiomyocyte ubiquitin-specific protease 25 (USP25) expression was downregulated both in myocardial tissue of obesity cardiomyopathy and palmitic acid-stimulated cardiomyocytes. USP25 deficiency exacerbated high-fat diet- induced ventricular remodeling in mice, whereas overexpression of USP25 in cardiomyocytes reversed this pathological phenotype. Mechanistically, USP25 directly binds to TAI<1 and P62, and the 178-cysteine of USP25 removes the I<63 ubiquitin chain from P62, which promotes the degradation of TAI<1 through the autophagylysosome pathway, thereby ameliorating obesity-induced ventricular remodeling by reducing inflammation through the TAI<1-MAPI< pathway. This finding identifies USP25 as a potential therapeutic target for obesity cardiomyopathy. (JACC Basic TranslSci. 2024;9:1287-1304) (c) 2024 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation. This is an open access article under the CC BY-NC- ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页码:1287 / 1304
页数:18
相关论文